The off-brand version comes just weeks after Novo Nordisk launched its reformulation of the blockbuster medication.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.

The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.

War breaks out over GLP-1 pills as Novo Nordisk takes legal action against Hims & Hers over compounded weight loss drugs.

Shares of of Hims & Hers (HIMS) rose 11% at market open on Thursday morning, while U.S.-listed shares of Novo Nordisk (NVO) ...

Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, ...

Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday discussing the company's tough recent outlook when ...

Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said it will ...

Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.

Sales of Novo Nordisk's blockbuster diabetes drug Ozempic in the greater China region fell for the first time last year, as ...